Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2017 at "American Journal of Hematology"
DOI: 10.1002/ajh.24732
Abstract: The Revised International Prognostic Scoring System (IPSS‐R) has been recognized as the score with the best outcome prediction capability in MDS, but this brought new concerns about the accurate prognostication of patients classified into the…
read more here.
Keywords:
category;
risk;
outcome prediction;
mds ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2017 at "American journal of hematology"
DOI: 10.1002/ajh.24862
Abstract: Word Count: N/A Main Text Word Count: 339 Number of References: 3 # Correspondence: Josehp D. Khoury, MD Department of Hematopathology The University of Texas MD Anderson Cancer Center Houston, Texas 77030 Phone: 713-745-2387 Fax:…
read more here.
Keywords:
aml mrc;
article;
pel;
mds ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2017 at "Cancer"
DOI: 10.1002/cncr.30532
Abstract: Myelodysplastic syndromes (MDS) are genetically, biologically, and clinically very heterogeneous. Although allogeneic stem cell transplantation (alloSCT) remains the only intervention with a potential for cure, less than 5% of patients undergo transplantation because of age…
read more here.
Keywords:
myelodysplastic syndromes;
histone deacetylase;
higher risk;
hypomethylating agents ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of Computational Chemistry"
DOI: 10.1002/jcc.26167
Abstract: Advances to the distributed, multi‐core and fully cross‐platform QuBiLS‐MIDAS software v2.0 (http://tomocomd.com/qubils-midas) are reported in this article since the v1.0 release. The QuBiLS‐MIDAS software is the only one that computes atom‐pair and alignment‐free geometrical MDs…
read more here.
Keywords:
information;
midas mds;
midas software;
qubils midas ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24677
Abstract: Clinically, to make a definite diagnosis of aplastic anemia (AA), idiopathic cytopenia of undetermined significance (ICUS) or myelodysplastic syndrome (MDS), they should be distinguished from each other. AA and ICUS have some incidence to transform…
read more here.
Keywords:
mds;
bone marrow;
marrow;
diagnosis ... See more keywords
Photo by grab from unsplash
Sign Up to like & get
recommendations!
0
Published in 2021 at "Macromolecular bioscience"
DOI: 10.1002/mabi.202000377
Abstract: Vascular-targeted drug delivery remains an attractive platform for therapeutic and diagnostic interventions in human diseases. This work focuses on the development of a poly-lactic-co-glycolic-acid (PLGA)-based multistage delivery system (MDS). MDS consists of two stages: a…
read more here.
Keywords:
based multistage;
delivery;
plga based;
mds ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2022 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.13390
Abstract: The association of movement disorders (MDs) with musculoskeletal (MSK) disorders is observed in two principal scenarios. First, MDs patients may present with MSK issues. This phenomenon is primarily observed in parkinsonian syndromes, but may also…
read more here.
Keywords:
movement disorders;
mds;
system;
msk disorders ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2021 at "Annals of Hematology"
DOI: 10.1007/s00277-020-04360-4
Abstract: SF3B1 is a highly mutated gene in myelodysplastic syndrome (MDS) patients, related to a specific subtype and parameters of good prognosis in MDS without excess blasts. More than 40% of MDS patients carry at least…
read more here.
Keywords:
biological prognostic;
clinical biological;
mds patients;
mds ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2022 at "Annals of Hematology"
DOI: 10.1007/s00277-022-04775-1
Abstract: Myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) can be late complications following mutagenic treatment. Limited data is available on the outcome of patients developing therapy-related MDS and AML after treatment for multiple myeloma (MM).…
read more here.
Keywords:
therapy related;
mds;
myeloma;
treatment multiple ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2020 at "Agroforestry Systems"
DOI: 10.1007/s10457-020-00552-z
Abstract: By using two thinning intensity regimes on a dense 16-year-old black locust (Robinia pseudoacacia L.) stand, two silvopastures were created: a medium density silvopasture (MDS) with 60% mean crown cover and a low density silvopasture…
read more here.
Keywords:
locust;
mds;
herbage;
forage ... See more keywords
Photo from archive.org
Sign Up to like & get
recommendations!
2
Published in 2017 at "Current Hematologic Malignancy Reports"
DOI: 10.1007/s11899-017-0407-9
Abstract: Purpose of ReviewThe purpose of this study is to review established prognostic models in myelodysplastic syndromes (MDS) and describe how molecular data can be used to improve patient risk stratification.Recent FindingsSomatic mutations are common in…
read more here.
Keywords:
risk;
molecular data;
data ipss;
risk stratification ... See more keywords